Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Corrigendum to "Comprehensive characterization of immune landscape of Indian and Western triple negative breast cancers": Translational Oncology 2022 Nov; 25:101511.
Korlimarla A, Hari PS, Prabhu J, Ragulan C, Patil Y, Snijesh VP, Desai K, Mathews A, Appachu S, Diwakar RB, Srinath BS, Melcher A, Cheang M, Sadanandam A. Korlimarla A, et al. Transl Oncol. 2023 Jan;27:101574. doi: 10.1016/j.tranon.2022.101574. Epub 2022 Nov 3. Transl Oncol. 2023. PMID: 36517200 Free PMC article. No abstract available.
Dissecting the Biological Heterogeneity within Hormone Receptor Positive HER2 Negative Breast Cancer by Gene Expression Markers Identifies Indolent Tumors within Late Stage Disease.
Prabhu JS, Korlimarla A, Anupama CE, Alexander A, Raghavan R, Kaul R, Desai K, Rajarajan S, Manjunath S, Correa M, Raman R, Kalamdani A, Prasad M, Patil S, Gopinath KS, Srinath BS, Sridhar TS. Prabhu JS, et al. Among authors: korlimarla a. Transl Oncol. 2017 Aug;10(4):699-706. doi: 10.1016/j.tranon.2017.04.011. Epub 2017 Jul 11. Transl Oncol. 2017. PMID: 28704710 Free PMC article.
High expression of integrin β6 in association with the Rho-Rac pathway identifies a poor prognostic subgroup within HER2 amplified breast cancers.
Desai K, Nair MG, Prabhu JS, Vinod A, Korlimarla A, Rajarajan S, Aiyappa R, Kaluve RS, Alexander A, Hari PS, Mukherjee G, Kumar RV, Manjunath S, Correa M, Srinath BS, Patil S, Prasad MS, Gopinath KS, Rao RN, Violette SM, Weinreb PH, Sridhar TS. Desai K, et al. Among authors: korlimarla a. Cancer Med. 2016 Aug;5(8):2000-11. doi: 10.1002/cam4.756. Epub 2016 May 17. Cancer Med. 2016. PMID: 27184932 Free PMC article.
The Impact of Breast Cancer on the Patient and the Family in Indian Perspective.
Alexander A, Kaluve R, Prabhu JS, Korlimarla A, Srinath BS, Manjunath S, Patil S, Gopinath KS, Sridhar TS. Alexander A, et al. Among authors: korlimarla a. Indian J Palliat Care. 2019 Jan-Mar;25(1):66-72. doi: 10.4103/IJPC.IJPC_158_18. Indian J Palliat Care. 2019. PMID: 30820105 Free PMC article.
HR+HER2- breast cancers with growth factor receptor-mediated EMT have a poor prognosis and lapatinib downregulates EMT in MCF-7 cells.
Desai K, Aiyappa R, Prabhu JS, Nair MG, Lawrence PV, Korlimarla A, Ce A, Alexander A, Kaluve RS, Manjunath S, Correa M, Srinath BS, Patil S, Kalamdani A, Prasad M, Sridhar TS. Desai K, et al. Among authors: korlimarla a. Tumour Biol. 2017 Mar;39(3):1010428317695028. doi: 10.1177/1010428317695028. Tumour Biol. 2017. PMID: 28349782 Free article.
Pre-Menopausal Women With Breast Cancers Having High AR/ER Ratios in the Context of Higher Circulating Testosterone Tend to Have Poorer Outcomes.
Rajarajan S, Korlimarla A, Alexander A, Anupama CE, Ramesh R, Srinath BS, Sridhar TS, Prabhu JS. Rajarajan S, et al. Among authors: korlimarla a. Front Endocrinol (Lausanne). 2021 Jun 21;12:679756. doi: 10.3389/fendo.2021.679756. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 34234742 Free PMC article.
27 results